Smallpox

Aventis Pasteur donates 75-90 million doses of vaccine to the U.S.

Published in TB and Outbreaks Week, April 23rd, 2002

Aventis Pasteur, the vaccine business of Aventis Pharma, has announced that it will donate its smallpox vaccine inventory to the U.S. government's emergency preparedness stockpiles.

The inventory is estimated to be between 75 and 90 million doses with the exact amount to be confirmed by clinical studies. The vaccine comes from the company's existing stock and has an estimated commercial value in excess of $150 million. It will provide a short-term safety stock for emergency use during this period of time in which the U.S. may be particularly vulnerable to a terrorist smallpox attack until new vaccine supplies are available.

The company has worked...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-04-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry